MA53553A - Traitement post-chirurgical de la douleur - Google Patents
Traitement post-chirurgical de la douleurInfo
- Publication number
- MA53553A MA53553A MA053553A MA53553A MA53553A MA 53553 A MA53553 A MA 53553A MA 053553 A MA053553 A MA 053553A MA 53553 A MA53553 A MA 53553A MA 53553 A MA53553 A MA 53553A
- Authority
- MA
- Morocco
- Prior art keywords
- surgical pain
- pain treatment
- post surgical
- post
- treatment
- Prior art date
Links
- 208000004550 Postoperative Pain Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862728732P | 2018-09-07 | 2018-09-07 | |
| US201962860190P | 2019-06-11 | 2019-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA53553A true MA53553A (fr) | 2021-07-14 |
Family
ID=68138775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA053553A MA53553A (fr) | 2018-09-07 | 2019-09-06 | Traitement post-chirurgical de la douleur |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20200078363A1 (fr) |
| EP (1) | EP3846811B1 (fr) |
| JP (2) | JP2021536477A (fr) |
| KR (1) | KR20210060492A (fr) |
| CN (1) | CN112955144A (fr) |
| AU (1) | AU2019337104B2 (fr) |
| BR (1) | BR112021004331A2 (fr) |
| CA (1) | CA3111570A1 (fr) |
| MA (1) | MA53553A (fr) |
| MX (1) | MX2021002556A (fr) |
| TW (1) | TW202023567A (fr) |
| WO (1) | WO2020051543A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11992485B2 (en) * | 2013-07-22 | 2024-05-28 | Hutchison Health, Llc | Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief |
| US11559521B2 (en) * | 2013-07-22 | 2023-01-24 | William Bradley Worthington | Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief |
| US11992484B2 (en) * | 2013-07-22 | 2024-05-28 | Hutchison Health, Llc | Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief |
| WO2019152430A1 (fr) * | 2018-01-30 | 2019-08-08 | Heron Therapeutics, Inc. | Méthode d'administration de formulations d'émulsions d'un antagoniste du récepteur de la nk-1 |
| CN115515581A (zh) * | 2020-01-10 | 2022-12-23 | 帕西拉制药股份有限公司 | 通过给予缓释脂质体麻醉组合物治疗疼痛 |
| CN115151207A (zh) * | 2021-01-29 | 2022-10-04 | 原位生物制剂有限公司 | 用于持续治疗疼痛的组合物和方法 |
| WO2023154293A1 (fr) * | 2022-02-08 | 2023-08-17 | Saint Cyr Michael Hector | Formulations anesthésiques et méthodes |
| CN116898977B (zh) * | 2022-07-20 | 2025-07-15 | 四川大学华西医院 | 一种麻醉镇痛的联合用药物 |
| CN116041342B (zh) * | 2022-12-30 | 2024-02-20 | 加立(深圳)生物科技有限公司 | 罗哌卡因/美洛昔康盐的一水合物i晶型、药物组合物及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002359404B2 (en) * | 2002-11-12 | 2008-06-05 | Omeros Corporation | Irrigation solution and method for inhibition of tumor cell adhesion, pain and inflammation |
| WO2007128056A1 (fr) * | 2006-05-03 | 2007-11-15 | Cnsbio Pty Ltd | Méthodes et composition pour traitement d'une douleur inflammatoire |
| EP2175886A1 (fr) * | 2007-06-28 | 2010-04-21 | CNSBio Pty Ltd | Procédés et compositions de combinaison pour le traitement d'une douleur neuropathique |
| US8992951B2 (en) * | 2013-01-09 | 2015-03-31 | Sapna Life Sciences Corporation | Formulations, procedures, methods and combinations thereof for reducing or preventing the development, or the risk of development, of neuropathology as a result of trauma |
| AU2014228313B2 (en) * | 2013-03-15 | 2019-01-17 | Heron Therapeutics, Inc. | Compositions of a polyorthoester and an aprotic solvent |
| US9801945B2 (en) * | 2014-04-21 | 2017-10-31 | Heron Therapeutics, Inc. | Long-acting polymeric delivery systems |
| PT3134068T (pt) * | 2014-04-21 | 2021-10-18 | Heron Therapeutics Inc | Sistemas de libertação poliméricos de longa duração |
| US11083730B2 (en) * | 2014-04-21 | 2021-08-10 | Heron Therapeutics, Inc. | Long-acting polymeric delivery systems |
-
2019
- 2019-09-06 MX MX2021002556A patent/MX2021002556A/es unknown
- 2019-09-06 MA MA053553A patent/MA53553A/fr unknown
- 2019-09-06 AU AU2019337104A patent/AU2019337104B2/en active Active
- 2019-09-06 US US16/563,726 patent/US20200078363A1/en not_active Abandoned
- 2019-09-06 CA CA3111570A patent/CA3111570A1/fr active Pending
- 2019-09-06 CN CN201980071058.6A patent/CN112955144A/zh active Pending
- 2019-09-06 WO PCT/US2019/050079 patent/WO2020051543A1/fr not_active Ceased
- 2019-09-06 TW TW108132238A patent/TW202023567A/zh unknown
- 2019-09-06 EP EP19783171.2A patent/EP3846811B1/fr active Active
- 2019-09-06 JP JP2021512699A patent/JP2021536477A/ja active Pending
- 2019-09-06 KR KR1020217009121A patent/KR20210060492A/ko not_active Ceased
- 2019-09-06 BR BR112021004331-4A patent/BR112021004331A2/pt unknown
-
2024
- 2024-10-21 JP JP2024184872A patent/JP2025010592A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3111570A1 (fr) | 2020-03-12 |
| US20200078363A1 (en) | 2020-03-12 |
| KR20210060492A (ko) | 2021-05-26 |
| BR112021004331A2 (pt) | 2021-08-03 |
| AU2019337104A1 (en) | 2021-03-25 |
| WO2020051543A1 (fr) | 2020-03-12 |
| JP2025010592A (ja) | 2025-01-22 |
| JP2021536477A (ja) | 2021-12-27 |
| TW202023567A (zh) | 2020-07-01 |
| CN112955144A (zh) | 2021-06-11 |
| MX2021002556A (es) | 2021-06-15 |
| AU2019337104B2 (en) | 2025-05-15 |
| EP3846811B1 (fr) | 2025-11-05 |
| EP3846811C0 (fr) | 2025-11-05 |
| EP3846811A1 (fr) | 2021-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA53553A (fr) | Traitement post-chirurgical de la douleur | |
| EP3813647A4 (fr) | Stimulation multimodale de traitement des tremblements | |
| EP3813808A4 (fr) | Méthodes de traitement de la toxicomanie | |
| EP4072456A4 (fr) | Cartographie et traitement tissulaire | |
| KR102199943B9 (ko) | 의료용 자극 장치 | |
| EP3397149A4 (fr) | Cartographie et traitement de tissu | |
| EP3648841A4 (fr) | Organe interne, lésion et traitement de la douleur | |
| EP3448263A4 (fr) | Traitement électrothérapeutique | |
| PT3773558T (pt) | Tratamento combinado de doença artrítica | |
| EP4076217A4 (fr) | Construction de traitement de la syndesmose | |
| EP3862000A4 (fr) | Médicament de traitement de la toux chronique | |
| EP3669791A4 (fr) | Forceps médicaux | |
| MA49440A (fr) | Elément de cicatrisation dentaire | |
| EP3592377A4 (fr) | Formes posologiques de kallicréine tissulaire 1 | |
| EP3773539A4 (fr) | Compositions pour le traitement de la peau | |
| EP3796877A4 (fr) | Dispositif de stimulation et de traitement | |
| EP3458062A4 (fr) | Traitement de la douleur | |
| EP3873528A4 (fr) | Traitement de rasopathie | |
| EP4069438C0 (fr) | Système de traitement de la peau | |
| IL280638A (en) | Fat tissue treatment | |
| EP3960924C0 (fr) | Appareil de traitement de vêtements | |
| EP3934549C0 (fr) | Dispositif de traitement de tissu | |
| EP3856207A4 (fr) | Procédés de traitement | |
| EP4405465A4 (fr) | Méthodes de traitement | |
| EP3773448C0 (fr) | Procédé de traitement des cheveux |